Clinical trial
A Phase I/II Study of SEL24 in Patients With Acute Myeloid Leukemia
NCT03008187 is registered in ClinicalTrials.gov with Menarini Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of SEL24 in Patients With Acute Myeloid Leukemia
- Lead sponsor
- Menarini Group
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 10, 2017
- Completion date
- April 13, 2023
- Enrollment
- 73 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
acute myeloid leukemia